| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |
| 07/03/2002 | EP1218403A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218378A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 07/03/2002 | EP1218375A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 07/03/2002 | EP1218373A2 2-pyrazolin-5-ones as tyrosine kinase inhibitors |
| 07/03/2002 | EP1218370A2 Quinolyl propyl piperidine derivatives and their use as antibacterial agents |
| 07/03/2002 | EP1218369A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/03/2002 | EP1218358A1 Therapeutic quinazoline compounds |
| 07/03/2002 | EP1218346A1 Pyrazole derivatives |
| 07/03/2002 | EP1218339A2 Benzyl amidoxime derivatives, intermediate products and method for their production and use as fungicides |
| 07/03/2002 | EP1218333A1 Anti-inflammatory nitro- and thia- fatty acids |
| 07/03/2002 | EP1218029A1 Use of an outer membrane protein a of an enterobacterium associated with a rsv immunogenic peptide for preparing vaccines for intranasal administration |
| 07/03/2002 | EP1218011A1 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, dna viruses and retroviruses |
| 07/03/2002 | EP1218000A1 Anti-cancer nitro- and thia-fatty acids |
| 07/03/2002 | EP1217996A1 Use of xanthophylls, astaxanthin e.g., for treatment of autoimmune diseases, chronic viral and intracellular bacterial infections |
| 07/03/2002 | EP1217989A1 Liposome-entrapped dna oral vaccines |
| 07/03/2002 | EP1217975A1 Using quaternary ammonium salts for transdermal drug delivery |
| 07/03/2002 | EP1217902A1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 07/03/2002 | EP1030690B1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 07/03/2002 | EP0983234B1 Leukotriene b 4 derivatives, in particular 7-methylcyclohexyl-ltb 4 antagonists |
| 07/03/2002 | EP0912085A4 Precise efficacy assay methods for active agents including chemotherapeutic agents |
| 07/03/2002 | EP0863769B1 Glycoconjugates as virus cell adhesion inhibitors |
| 07/03/2002 | EP0777669B1 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent |
| 07/03/2002 | CN1357046A Chitinase chitin-binding fragments |
| 07/03/2002 | CN1357045A Outer surface proteins, their genes, and their use |
| 07/03/2002 | CN1357038A Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions |
| 07/03/2002 | CN1357002A Compositions for treating inflammatory response |
| 07/03/2002 | CN1357001A Novel ribose-substituted aromatic amides, method for prodn. and use thereof as medicaments |
| 07/03/2002 | CN1356997A Thiophene-ethyl thiourea compounds and their use in treatment of HIV |
| 07/03/2002 | CN1356907A Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/03/2002 | CN1356905A Leaves of cajanus cajan(L.) millsp and extract, formulation and uses thereof |
| 07/03/2002 | CN1356902A IL-8 receptor antagonists |
| 07/03/2002 | CN1356899A IL-8 receptor antagonists |
| 07/03/2002 | CN1356143A Emulsion-type lubricant and its application in medical rubber product |
| 07/03/2002 | CN1356142A Therapeutic vaccine for hepatitis B and its preparing process |
| 07/03/2002 | CN1356126A Medicine for treating tuberculosis |
| 07/03/2002 | CN1356111A Medicine for treating tinea |
| 07/03/2002 | CN1356107A Freezing-dried injection powder 'Katisu' and its preparing process |
| 07/03/2002 | CN1356061A Multi-purpose high-function solution composition, its preparing process and its usage as non-specific immanopotentiator |
| 07/03/2002 | CN1086947C Chinese medicine prepn. for curing radically chronic tonsilitis and intractable laryngopharyngitis and its prepn. method |
| 07/02/2002 | US6414142 Concurrently adding solution of potassium 2-ethyl hexanoate in isopropanol and solution of tertiary-butylamino clavulanate in aqueous isopropanol to mixture of isopropanol and acetone, precipitating potassium clavulanate as rosette-like starbursts |
| 07/02/2002 | US6414132 Method of eliminating inhibitory/instability regions of mRNA |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414036 Composition for treatment of infections of humans and animals |
| 07/02/2002 | US6414035 Candida infections |
| 07/02/2002 | US6414032 Anti-infective compositions for treating disordered tissue such as cold sores |
| 07/02/2002 | US6414025 Rheumatic disorders; antiinflammatory agents; autoimmune diseases |
| 07/02/2002 | US6414013 Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| 07/02/2002 | US6414004 3-substituted 5-aryl-4-isoxazolecarbonitriles having antiviral activity |
| 07/02/2002 | US6413981 Drug-resistant gram positive and gram negative bacteria; pneumonia; infections of upper and lower respiratory tract, skin, soft tissue, bones and joints |
| 07/02/2002 | US6413970 Pharmaceutical composition for treating viral diseases |
| 07/02/2002 | US6413969 Gatifloxacin pentahydrate |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 07/02/2002 | US6413958 For treatment/prevention of infection of herpes simplex virus, varicella zoster virus, human cytomegalovirus, or epstein-barr virus; enzyme inhibitors |
| 07/02/2002 | US6413952 Agonizing dimeric cell-surface receptors with a receptor binding moiety and chelating metal |
| 07/02/2002 | US6413938 Herpes virus |
| 07/02/2002 | US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity |
| 07/02/2002 | US6413771 Respiratory syncytial virus (rsv) fusion protein; treating or preventing rsv infection, as well as for diagnosis of rsv in analytes |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413754 Candida albicans protein kinase which lacks a specific motif and has non-cyclin dependent cdk-activating activity; drug screening for fungicides |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413537 Nystatin formulation having reduced toxicity |
| 07/02/2002 | US6413524 spsA polynucleotides and polypeptides |
| 07/02/2002 | US6413522 Papilloma viruses, products for the detection thereof as well as for treating diseases caused by them |
| 07/02/2002 | US6413520 Methods of immunizing adults using anti-meningococcal vaccine compositions |
| 07/02/2002 | US6413518 Immunologically significant herpes simplex virus antigens and methods for identifying and using same |
| 07/02/2002 | US6413517 Identification of broadly reactive DR restricted epitopes |
| 07/02/2002 | US6413510 Dimeric modified groβ protein |
| 07/02/2002 | US6413507 Modified polyether |
| 07/02/2002 | US6413405 Active carbon electro-deposited with Ag-I system having sterilizing effect |
| 07/02/2002 | CA2253837C Therapeutic uses of bpi protein products for human meningococcemia |
| 07/02/2002 | CA2109601C Amide derivatives of antibiotic a 40926 |
| 07/02/2002 | CA2083172C Protein d - an igd-binding protein of haemophilus influenzae |
| 07/02/2002 | CA2073486C Composition for the prevention of lyme disease and use for |
| 07/02/2002 | CA2065846C Quinolone carboxylic acid derivatives |
| 07/02/2002 | CA2050749C Nucleotide sequence coding for an outer membrane protein from neisseria meningitidis and use of said protein in vaccine preparations |
| 06/27/2002 | WO2002050545A2 Compositions and methods involving staphylococcus aureus protein staau-r9 |
| 06/27/2002 | WO2002050536A2 Replication assay for detecting anti-viral substances |
| 06/27/2002 | WO2002050289A1 Methods for the production of multimeric proteins, and related compositions |
| 06/27/2002 | WO2002050287A2 Multifunctional protease inhibitors and their use in treatment of disease |
| 06/27/2002 | WO2002050279A2 Nucleic acid-associated proteins |
| 06/27/2002 | WO2002050270A1 Novel tissue-specific secretory polypeptide and dna thereof |
| 06/27/2002 | WO2002050265A1 Novel transmembrane receptor-like proteins and dnas thereof |
| 06/27/2002 | WO2002050255A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 06/27/2002 | WO2002050120A2 High affinity antibodies |
| 06/27/2002 | WO2002050119A2 Method for modulating the binding activity of a novel icam-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/27/2002 | WO2002050108A2 Immunogenic glycopeptides, screening, preparation and uses |
| 06/27/2002 | WO2002050107A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/27/2002 | WO2002050106A2 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4 |
| 06/27/2002 | WO2002050101A1 Retinoblastoma-binding protein |
| 06/27/2002 | WO2002050093A2 Methods utilizing aryl thioimines in synthesis of erythromycin derivatives |
| 06/27/2002 | WO2002050092A1 Macrolide antibiotics |
| 06/27/2002 | WO2002050091A1 Macrolide antibiotics |
| 06/27/2002 | WO2002050084A2 Streptogramin derivatives preparation thereof and compositions containing same |
| 06/27/2002 | WO2002050083A1 Streptogramin derivatives, preparation thereof and compositions containing same |
| 06/27/2002 | WO2002050082A2 Inhibitors of papilloma virus |
| 06/27/2002 | WO2002050081A2 Antimicrobial agents |
| 06/27/2002 | WO2002050079A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |